wada semaglutide Ozempic On WADA's Monitoring List For 2025 Use of GLP-1 Drugs Under
Description
Conjugation of PSMA-11 with the radioactive isotope Ga-68 enables its application in PET/CT imaging
While Lilly and Novo Nordisk lead today with high-efficacy peptides and multi-agonists, Pfizers diversified pipeline could allow them to carve out a unique space by the 2030s, especially if their monthly GLP-1 and oral combo strategies deliver on tolerability and efficacy
The role of small intestinal bacterial overgrowth in Parkinsons disease
A maggio 2025, pi di 1'800 casi sono ancora pendenti, con i primi processi previsti per il 2026
Thyroid disrupting chemicals
Open 2024, 7, e2413172
/media/img/mt/2026/06/2026_06_15_GLP_1s/original.jpg){kind=icon}
